Professional Documents
Culture Documents
FT-IR Spectrophotometric Analysis of Ascorbic Acid and Biotin and Their Pharmaceutical Formulations
FT-IR Spectrophotometric Analysis of Ascorbic Acid and Biotin and Their Pharmaceutical Formulations
FT-IR Spectrophotometric Analysis of Ascorbic Acid and Biotin and Their Pharmaceutical Formulations
PHARMACEUTICAL ANALYSIS
1321
1322 A. A. Bunaciu et al.
INTRODUCTION
The techniques used for the assay of ascorbic acid and biotin are
high-performance liquid chromatography (HPLC; Gioia et al. 2008;
Chaistain, Bowers-Komrod, and McCormick 1985), spectrophotometry
(Meng et al. 2008; Ozyurek et al. 2007), and solid-phase 125I-avidin assay
techniques (Tolymat and Mock 1989). There are some studies regarding
FT-IR analysis of ascorbic acid (Lohmann, Pagel, and Penka 1984) and
biotin (Swamy, Heimburg, and Marsh 1996).
The aim of the present study is to investigate the potential of FT-IR
spectrometry to quantify vitamin C and vitamin H in pharmaceutical pre-
parations. The proposed analytical method in this study was performed
on standards of vitamin C and vitamin H and four different pharmaceu-
tical formulations (namely Biotin, sample A, containing about 1000 mg of
vitamin H per tablet; Cevarol, sample B, containing about 500 mg of
vitamin C per tablet; Supradyn, sample C, containing about 150 mg
of vitamin C and 0.25 mg of vitamin H per tablet).
The main objective of this work was to develop a chemometric proce-
dure for the fast and accurate determination of the two active principles
under study. The Beer-Lambert law and=or principal component regres-
sion plus (PCRþ) and partial least squares (PLC) approaches, reducing
the sample pretreatment, and providing direct FT-IR measurement.
EXPERIMENTAL
Apparatus
Ascorbic acid and biotin standards used for this study were provided
by Sigma (St. Louis, MO) and Merck (Darmstadt, Germany) respec-
tively. The pharmaceuticals were manufactured by Nature Bounty,
Inc., Bohemia, NY, USA (BIOTIN1 1000 mmg=tablet, sample A), by
Memphis Co. for Pharmaceutical and Chemical Industries Cairo, Egypt
(CEREVOL1 500 mg=tablet ascorbic acid, sample B), and by Euro-
pharm Braşov Romania (SUPRADYN1 150 mg of ascorbic acid and
250 mg biotin per tablet, sample C), respectively. Spectral grade KBr from
Merck was used for disk preparation.
1324 A. A. Bunaciu et al.
Recommended Procedures
Figures 2 and 3 show the spectra of standard ascorbic acid and biotin
as well as for the pharmaceutical preparations using the KBr disk
method.
Figure 2. FT-IR standard spectra for ascorbic acid and biotin, respectively.
FT-IR Spectrophotometric Analysis of Ascorbic Acid and Biotin 1325
CONCLUSIONS
REFERENCES
Chaistain, J., M. Bowers-Komrod, and D. B. McCormick. 1985. High-performance
liquid chromatography of biotin and analogues. J. Chromatogr. 33: 153–158.
Ciurczak, E. W., and J. K. Drennen III. 2001. Pharmaceutical and Medical Appli-
cations of Near-Infrared Spectroscopy. New York: Marcel Dekker.
Garrigues, S., M. Gallignani, and M. de la Guardia. 1992. Simultaneous determi-
nation of ortho-, meta- and para-xylene by flow injection-Fourier transform
infrared spectroscopy. Analyst 117: 1849–1853.
Gioia, M. G., P. Andreatta, S. Boschetti, and R. Gatti. 2008. Development and
validation of a liquid chromatographic method for the determination of ascor-
bic acid, dehydroascorbic acid, and acetaminophen in pharmaceuticals.
J. Pharm. Biomed. Anal. 48: 331–339.
Holmberg, A., A. Blomstergren, O. Nord, M. Lukacs, J. Lundberg, and M.
Uhlen. 2005. The biotin-streptavidin interaction can be reversibly broken using
water at elevated temperatures. Electrophoresis 26: 501–510.
Li, R., K. Byers, and R. R. Walvekar. 2008. Gingival hypertrophy: A solitary
manifestation of scurvy. Amer. J. Otolarynol. 29: 426–442.
Lohmann, W., D. Pagel, and V. Penka. 1984. Structure of ascorbic acid and its
biological function. Eur. J. Biochem. 138: 479–480.
McClure, W. F. 1992. Analysis using Fourier transforms. In Handbook of
Near-Infrared Analysis, ed. D. A. Burns and E. W. Ciurczak, 181–274. New
York: Marcel Dekker.
McCluskey, E. S. 1985. Which vertebrates make vitamin C? Origins 12: 96–100.
Meng, Q.-F., L.-S. Teng, C.-J. Jiang, J.-S. An, L. Li, J.-H. Lu, and L.-R. Teng.
2008. First-order derivative spectrophotometry for the determination of
vitamin C in medicament. Chem. Res. Chin. Uni. 24: 29–31.
Miller, B. E., N. D. Danielson, and J. E. Katon. 1988. Aqueous infrared pharma-
ceutical analysis of two choline compounds by flow injection analysis using the
circle cell. Appl. Spectroscopy 42: 401–405.
Moffat, A. C., ed. 1986. Clarke’s Isolation and Identification of Drugs, 2nd ed.
London: Pharmaceutical Society of Great Britain.
Moyad, M. A., and M. A. Combs. 2007. Vitamin C dietary supplements:
An objective review of the clinical evidence, part I. Seminars Prevent. Alternat.
Med. 3: 25–35.
Özyürek, M., K. Güçlü, B. Bektaşoğlu, and R. Apak. 2007. Spectrophotometric
determination of ascorbic acid by the modified CUPRAC method with extrac-
tive separation of flavonoids-La(III) complexes. Anal. Chim. Acta 588: 88–95.
Swamy, M. J., T. Heimburg, and D. Marsh. 1996. Fourier-transform infrared
spectroscopic studies on avidin secondary structure and complexation with
biotin and biotin-lipid assemblies. Biophys. J. 71: 840–847.
Tolaymat, N., and M. D. Mock. 1989. Biotin analysis of commercial vitamin and
other nutritional supplements. J. Nutrition 119: 1357–1360.
Velandia, B., R. M. Centor, V. McConnel, and M. Shah. 2008. Scurvy is still
present in developed countries. J. Gen. Intern. Med. 23: 1281–1284.
United States Pharmacopoeia, 22nd ed. 1990. Pharmacopeial Convention,
Rockville, MD.
Copyright of Analytical Letters is the property of Taylor & Francis Ltd and its content may not be copied or
emailed to multiple sites or posted to a listserv without the copyright holder's express written permission.
However, users may print, download, or email articles for individual use.